We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




European Markets Experience Growth for Oxygen Therapy Devices

By HospiMedica staff writers
Posted on 26 Jun 2007
The rising incidence of chronic obstructive pulmonary disease (COPD) is resulting in an increase in the number of people requiring oxygen therapy treatment, thereby leading to growth in the European oxygen therapy devices market. More...


These are the latest findings from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm. Moreover, with increasing pressure to reduce healthcare expenditure, the home care segment has been given preference and has become a huge revenue generator for the oxygen therapy devices markets. Improvements in the reimbursement system and development of a well-established network of distributors to provide service for the growing home care market are other favorable factors that are influencing market growth.

The markets have grown due to the use of increasingly sophisticated portable devices, causing a shift the traditional use of oxygen stored in large-sized cylinders. This has added value to manufacturers existing product line. The development of new products to cater to all sections of the COPD population has helped the market grow steadily.

"There has been a steady increase in the incidence of COPD in the last decade, which has resulted in greater need for supplementary oxygen,” said Frost & Sullivan research analyst Sowmya Rajagopalan. "Moreover, there have been several promotional programs to increase awareness of COPD and showcase the differences between COPD and asthma, which have enabled quick and accurate diagnosis of COPD.”

Frost & Sullivan found that the European markets for oxygen therapy devices earned revenues of US$232.7 million in 2006 and estimates this to reach $354.5 million in 2013.


Related Links:
Frost & Sullivan

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Shoulder System
Identity Shoulder System
New
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A microneedle array worn on top of the wrist measures glucose, alcohol and lactate levels in the interstitial fluid under the skin (Photo courtesy of An-Yi Chang/UC San Diego)

Wristband Sensor Provides All-In-One Monitoring for Diabetes and Cardiovascular Care

Diabetes management is a complex and evolving challenge, particularly when it comes to accurately tracking and understanding how various factors affect blood sugar levels and overall health.... Read more

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.